TrialThe Journal of clinical investigation2000

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.

P W Duda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.